Asian Journal of Andrology

INVITED REVIEW
Year
: 2018  |  Volume : 20  |  Issue : 2  |  Page : 138--144

Testosterone treatment and cardiovascular events in prescription database studies


Molly M Shores 
 Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, VA Puget Sound Health Care System, 1660 South Columbian Way Seattle, WA 98108, USA

Correspondence Address:
Molly M Shores
Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, VA Puget Sound Health Care System, 1660 South Columbian Way Seattle, WA 98108, USA

Over the past decade, there has been a substantial increase in the number of men who are treated with testosterone. Despite this increase in the use of testosterone, the risks of adverse cardiovascular events are unclear as meta-analyses have reported conflicting findings and no clinical studies have been large enough or long enough to adequately assess for cardiovascular risks. The goal of this paper is to review large prescription database studies of testosterone treatment and adverse cardiovascular events and mortality with the aim of providing some guidance for clinicians and researchers in this controversial area.


How to cite this article:
Shores MM. Testosterone treatment and cardiovascular events in prescription database studies.Asian J Androl 2018;20:138-144


How to cite this URL:
Shores MM. Testosterone treatment and cardiovascular events in prescription database studies. Asian J Androl [serial online] 2018 [cited 2020 Apr 10 ];20:138-144
Available from: http://www.ajandrology.com/article.asp?issn=1008-682X;year=2018;volume=20;issue=2;spage=138;epage=144;aulast=Shores;type=0